bio Genous
About:
bio Genous provides biomedical scientific research and drug development services.
Website: http://www.biogenous.cn/
Top Investors: Marathon Venture Partners, CMG-SDIC Capital Management
Description:
bio Genous provides biomedical scientific research, drug development, and clinical precision medicine services. They offer services that include organoid automation equipment, multi-tissue full-process kits, organoid culture and sample library construction technical solutions, organoid drug development, and precision medical subsystems.
Total Funding Amount:
90M CNY
Headquarters Location:
Hangzhou, Zhejiang, China
Founded Date:
2022-07-01
Contact Email:
info(AT)biogenous.cn
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-01-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai